%0 Journal Article
%A Lacroix, Jeannine Ariane Desiree
%A Schlund, Franziska
%A Leuchs, Barbara
%A Adolph, Kathrin
%A Sturm, Dominik
%A Bender, Sebastian
%A Hielscher, Thomas
%A Pfister, Stefan
%A Witt, Olaf
%A Rommelaere, Jean
%A Schlehofer, Jörg R
%A Witt, Hendrik
%T Oncolytic effects of parvovirus H-1 in medulloblastoma are associated with repression of master regulators of early neurogenesis.
%J International journal of cancer
%V 134
%N 3
%@ 0020-7136
%C Bognor Regis
%I Wiley-Liss
%M DKFZ-2017-03902
%P 703 - 716
%D 2014
%X Based on extensive pre-clinical studies, the oncolytic parvovirus H-1 (H-1PV) is currently applied to patients with recurrent glioblastoma in a phase I/IIa clinical trial (ParvOryx01, NCT01301430). Cure rates of about 40
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:23852775
%2 pmc:PMC4232887
%R 10.1002/ijc.28386
%U https://inrepo02.dkfz.de/record/127880